(:FLDM)

Apr 04, 2022 05:30 pm ET
Fluidigm Completes $250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc.
Fluidigm Corporation (Nasdaq:FLDM) today announced the closing of the previously announced strategic capital infusion from leading life sciences investors Casdin Capital, LLC (“Casdin”) and Viking Global Investors LP (“Viking”). Fluidigm has been...
Apr 01, 2022 04:05 pm ET
Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion
Fluidigm Corporation (Nasdaq:FLDM) today announced that its stockholders have voted to approve all of the proposals related to the previously announced strategic capital infusion from leading life sciences investors Casdin Capital, LLC (“Casdin”)...
Mar 29, 2022 09:29 am ET
Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking Global
Fluidigm Corporation (Nasdaq:FLDM) today announced that it has entered into a support agreement with Caligan Partners LP ("Caligan"), Fluidigm’s current largest holder of common stock, under which Caligan has agreed to vote “FOR” all Fluidigm...
Mar 28, 2022 08:30 am ET
Fluidigm Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution
Fluidigm Corporation (NASDAQ:FLDM) today announced that it has entered into an agreement with Casdin Capital, LLC (“Casdin”) and Viking Global Investors LP (“Viking”) modifying the provision of the proposed strategic capital infusion transaction...
Mar 25, 2022 04:00 pm ET
Fluidigm Adjourns Special Meeting of Stockholders Until April 1, 2022
Fluidigm Corporation (NASDAQ:FLDM) today announced that it convened and then adjourned, without conducting any other business, the Company’s Special Meeting of Stockholders (the “Special Meeting”) to provide stockholders additional time to vote on...
Mar 21, 2022 08:00 am ET
Fluidigm Urges Stockholders to Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion TODAY
Fluidigm Corporation (NASDAQ:FLDM) today urged Fluidigm stockholders to vote “FOR” ALL proposals related to the previously announced strategic capital infusion from leading life sciences investors Casdin Capital, LLC (“Casdin”) and Viking Global...
Mar 17, 2022 05:58 pm ET
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Fluidigm Stockholders Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion
Fluidigm Corporation (NASDAQ:FLDM), today announced that leading independent proxy advisory firms Institutional Shareholder Services (“ISS”) and Glass, Lewis & Co. (“Glass Lewis”) have recommended that Fluidigm stockholders vote “FOR” ALL proposals...
Feb 17, 2022 05:43 pm ET
Fluidigm Announces Fourth Quarter and Full Year 2021 Financial Results 
Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced financial results for the fourth quarter and full year ended December 31, 2021....
Feb 17, 2022 08:30 am ET
Fluidigm Announces Collaboration Agreement with the Abu Dhabi Stem Cells Center to Accelerate Imaging Mass Cytometry in Development of Targeted Stem Cell Therapies
Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a collaboration agreement with the Abu Dhabi Stem Cells Center (ADSCC) for...
Feb 14, 2022 06:10 am ET
Fluidigm Files Preliminary Proxy Statement in Connection with Proposed Strategic Capital Infusion from Casdin Capital and Viking Global Investors
Fluidigm Corporation (Nasdaq:FLDM) today filed with the U.S. Securities and Exchange Commission (the “SEC”) a preliminary proxy statement for a special meeting of stockholders (the “Special Meeting”) at which Fluidigm stockholders will have the...
Jan 24, 2022 08:30 am ET
Fluidigm Announces $250 Million Strategic Capital Infusion from Casdin Capital and Viking Global Investors and Rebranding to Standard BioTools Inc.
Fluidigm Corporation (NASDAQ:FLDM), today announced that its Board of Directors has unanimously approved a $250 million investment by leading life sciences investors Casdin Capital, LLC (“Casdin”) and Viking Global Investors LP (“Viking”)....
Jan 11, 2022 08:00 am ET
Fluidigm Announces Preliminary Revenue Exceeding Guidance for the Fourth Quarter and Full Year 2021
Fluidigm Corporation (NASDAQ: FLDM) today announced preliminary revenue for the fourth quarter and full year ended December 31, 2021, exceeding the company’s guidance for those periods. Fourth Quarter Revenue Highlights Fourth quarter 2021 total...
Dec 07, 2021 08:30 am ET
Fluidigm Confirms Advanta Dx SARS-CoV-2 RT-PCR Assay on the Company’s Biomark Platform Detects Omicron Variant of COVID-19
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today confirmed that Omicron variant B.1.1.529, designated by the World Health Organization as a...
Nov 16, 2021 08:30 am ET
Fluidigm to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that Chris Linthwaite, President and CEO, and Vikram Jog, Chief Financial Officer,...
Nov 11, 2021 08:30 am ET
Biomark X Offers Industry-Leading Advantages in Speed, Throughput, Flexibility and Cost
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the launch of Biomark™ X, the latest generation of its industry-leading Biomark...
Nov 08, 2021 04:02 pm ET
Fluidigm Announces Third Quarter 2021 Financial Results
Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced financial results for the third quarter ended September 30, 2021. “We saw a very...
Nov 08, 2021 08:30 am ET
Imaging Mass Cytometry Utilized to Seek Molecular Links between African Ancestry and Aggressive Forms of Breast and Prostate Cancer
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that Imaging Mass Cytometry™ (IMC™) is being utilized in studies led by researchers...
Oct 20, 2021 08:30 am ET
Fluidigm Announces Conference Call and Webcast of Third Quarter 2021 Financial Results
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will report third quarter 2021 financial results on Monday, November 8, 2021,...
Oct 18, 2021 08:30 am ET
Fluidigm 2021 IMC Summit Focuses on ‘Uncovering Spatial Biology’
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the agenda for its IMC™ Summit: Uncovering Spatial Biology. The October 21 virtual...
Oct 12, 2021 08:30 am ET
Fluidigm Announces New Co-Marketing Program under Collaboration Agreement with Visiopharm, Offering AI-Based Image Analysis Software
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a new co-marketing program to offer Visiopharm® image analysis software for faster...
Sep 28, 2021 08:30 am ET
Fluidigm Announces Collaboration Agreement with Karolinska Institutet to Accelerate Customer Adoption of New CyTOF XT
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a collaboration agreement with the Karolinska Institutet for research applications...
Sep 02, 2021 08:30 am ET
Fluidigm to Participate in the Cantor Virtual Global Healthcare Conference
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that Chris Linthwaite, President and CEO, and Vikram Jog, Chief Financial Officer,...
Aug 31, 2021 08:30 am ET
CyTOF and Maxpar Direct Technologies Utilized in Study Characterizing Immune and Inflammatory Responses in Pregnant Women Infected with SARS-CoV-2
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the publication of new data further validating the potential of its mass cytometry...
Aug 09, 2021 11:14 am ET
Fluidigm to Participate in UBS Genomics 2.0 and MedTech Innovations Summit
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that company management will participate in the following investor event: UBS...
Aug 05, 2021 04:05 pm ET
Fluidigm Announces Second Quarter 2021 Financial Results with Total Revenue of $31.0 Million
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced financial results for the second quarter ended June 30, 2021. “Second quarter...
Aug 05, 2021 09:30 am ET
Ultivue Announces Co-Marketing Agreement with Fluidigm for Biomarker Imaging Solutions for Precision Medicine
Ultivue, Inc. and Fluidigm Corporation (Nasdaq:FLDM) today announced a co-marketing agreement in which the companies will offer customers a comprehensive portfolio of workflow solutions for biomarker discovery and drug development.
Aug 05, 2021 08:35 am ET
Fluidigm Announces Collaboration Agreement with Imaging CRO ImaBiotech to Increase Biopharma Access to Imaging Mass Cytometry
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a collaboration and co-marketing agreement with ImaBiotech for service offerings and...
Aug 05, 2021 08:30 am ET
Fluidigm Announces Co-Marketing Agreement with Ultivue for Biomarker Imaging Solutions for Precision Medicine
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a co-marketing agreement with Ultivue, Inc., under which the companies will offer a...
Jul 28, 2021 08:30 am ET
Thinking about buying stock in Infinity Pharmaceuticals, US Well Services, Constellium, Fluidigm, or TAL Education?
NEW YORK, July 28, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for INFI, USWS, CSTM, FLDM, and TAL.
Jul 08, 2021 04:01 pm ET
Fluidigm Announces Conference Call and Webcast of Second Quarter 2021 Financial Results
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will report second quarter 2021 financial results on Thursday, August 5,...
Jun 17, 2021 07:30 am ET
Rover Labs Provides Saliva-based COVID-19 Testing to New York City Public Schools
NEW YORK, June 17, 2021 /PRNewswire/ -- Rover Labs, a diagnostics technology leader in end-to-end saliva testing, is providing saliva-based COVID-19 testing to approximately 50 New York City public schools during a two-month pilot program that began on June 1 using technology developed by Fluidigm Corporation (Nasdaq:FLDM).
May 25, 2021 02:00 pm ET
Next-Generation CyTOF XT Redefines Cytometry with Advances in Automation, Throughput, Time to Results and Total Cost of Ownership
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the launch of CyTOF® XT, designed to simplify the design and execution of deep cell...
May 24, 2021 08:30 am ET
Imaging Mass Cytometry Utilized by Global Consortium Focused on New Precision Medicine Approaches for Treatment of Rheumatoid Arthritis
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it has joined the FLAMIN-GO Project consortium of academic and industry leaders...
May 14, 2021 08:30 am ET
Fluidigm to Present at Upcoming Investor Conferences
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that the company’s management will participate in several upcoming investor...
May 10, 2021 01:30 pm ET
Fluidigm Announces Virtual Mass Cytometry Webinar Investor Event on May 24, 2021, at 1:00 p.m. Eastern Time
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will host a virtual investor event that will showcase competitive advantages...
May 06, 2021 04:05 pm ET
Fluidigm Announces First Quarter 2021 Financial Results with Total Revenue of $32.8 Million, Up 19 Percent Over Prior Year Period
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced financial results for the first quarter ended March 31, 2021. “We delivered solid...
May 06, 2021 08:30 am ET
Data Published in Nature Communications Demonstrate the Power of Fluidigm’s CyTOF and Imaging Mass Cytometry Technologies to Transform Cancer Drug Discovery and Enable New Precision Medicine Approache
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the publication of data that further validate the potential of its mass cytometry...
Apr 08, 2021 08:30 am ET
Fluidigm Announces Conference Call and Webcast of First Quarter 2021 Financial Results
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will report first quarter 2021 financial results on Thursday, May 6, 2021,...
Mar 01, 2021 08:30 am ET
FDA Grants Emergency Use Authorization for Home Collection Kit for Advanta Dx SARS-CoV-2 RT-PCR Assay
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use...
Feb 10, 2021 04:05 pm ET
Fluidigm Announces Fourth Quarter and Full Year 2020 Financial Results
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced financial results for the fourth quarter and full year ended December 31, 2020....
Feb 10, 2021 04:02 pm ET
Fluidigm Announces Collaboration with Zhejiang PuLuoTing Health Technology Co. Ltd to Market Fluidigm CyTOF Technology to Clinical Labs in China
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a supply and distribution agreement with Zhejiang PuLuoTing Health Technology Co. Ltd...
Feb 10, 2021 04:02 pm ET
George Mason University Providing COVID-19 Testing with Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay on Biomark HD Platform
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that George Mason University in Fairfax, Va., is providing saliva-based COVID-19...
Feb 09, 2021 08:30 am ET
NIH Sponsored Study at Stanford University School of Medicine to Utilize Fluidigm Mass Cytometry Technology and Maxpar Direct Immune Profiling Assay to Evaluate Immune Responses in Pediatric Patients
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that Fluidigm® mass cytometry technology and the Maxpar® Direct™ Immune Profiling...
Feb 04, 2021 04:02 pm ET
Fluidigm to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that the company’s management will participate in investor meetings at the BTIG...
Jan 26, 2021 08:30 am ET
Helix Specialty Diagnostics Partners with Genomic LTC DX to Provide COVID-19 Testing with Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay on Biomark HD Platform
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that Helix Specialty Diagnostics is partnering with Genomic LTC DX to provide...
Jan 22, 2021 07:30 am ET
Thinking about buying stock in iBio, Fluidigm Corp, Atossa Therapeutics, BioCryst Pharmaceuticals, or GameStop?
NEW YORK, Jan. 22, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for IBIO, FLDM, ATOS, BCRX, and GME.
Jan 21, 2021 04:05 pm ET
Fluidigm Receives CE-IVD Mark for Its Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay for COVID-19
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that the company has received the CE-IVD mark for its Advanta™ Dx SARS-CoV-2 RT-PCR...
Jan 07, 2021 04:02 pm ET
Fluidigm Announces Conference Call and Webcast of Fourth Quarter and Full Year 2020 Financial Results
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will report fourth quarter and full year 2020 financial results on Wednesday,...
Jan 05, 2021 08:30 am ET
New Data Published in Gastroenterology Demonstrate the Power of Fluidigm’s Imaging Mass Cytometry on the Hyperion Imaging System to Identify Novel Targets for Pancreatic Cancer Therapy
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the publication of a new study led by Georgetown Lombardi Comprehensive Cancer Center...
Dec 15, 2020 04:05 pm ET
Dr. Ana K. Stankovic, MD, PhD, Appointed to Fluidigm Board of Directors
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the appointment of Dr. Ana K. Stankovic, MD, PhD, MSPH, to the company’s Board of...
Nov 24, 2020 08:30 am ET
Key Regulatory Body in India Grants Commercial License for Fluidigm Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that the Central Drugs Standard Control Organisation (CDSCO) in India has licensed...
Nov 22, 2020 11:37 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fluidigm Corporation - FLDM
Pomerantz LLP is investigating claims on behalf of investors of Fluidigm Corporation (“Fluidigm” or the “Company”) (NASDAQ: FLDM).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Nov 20, 2020 09:54 pm ET
Fluidigm to Participate at the Piper Sandler 32nd Annual Virtual Healthcare Conference
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that the company’s management will participate in the Piper Sandler 32nd Annual...
Nov 20, 2020 08:51 am ET
FLDM FINAL DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Reminds Fluidigm Corporation Investors of Important November 20 Deadline in Securities Class Action – FLDM
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fluidigm Corporation (NASDAQ: FLDM) between February 7, 2019 and November 5, 2019, inclusive (the “Class Period”) of the important November 20, 2020 lead...
Nov 19, 2020 11:00 am ET
FLDM Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fluidigm Corporation Investors of Class Action and Lead Plaintiff Deadline: November 20, 2020
Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fluidigm Corporation ("Fluidigm” or "the Company") (NASDAQ: FLDM) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Fluidigm securities between February 7, 2019 and November 5, 2019, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm’s site:
Nov 19, 2020 10:54 am ET
NOV. 20 DEADLINE Pawar Law Group Announces a Securities Class Action Lawsuit Against Fluidigm Corporation– FLDM
Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Fluidigm Corporation (NASDAQ: FLDM) from February 7, 2019 through November 5, 2019, inclusive (the “Class Period”). The lawsuit...
Nov 19, 2020 08:30 am ET
Study Utilizing Imaging Mass Cytometry Details Changes in Lung Tissue Architecture at the Single-Cell Level in Patients with COVID-19
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that researchers at Weill Cornell Medicine have identified a phenotype of immune cell...
Nov 19, 2020 08:00 am ET
Fluidigm Corporation Investors: Last Days to Participate Actively in the Class Action Lawsuit: Portnoy Law Firm
The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Fluidigm Corporation (NASDAQ: FLDM) investors that acquired shares between February 17, 2019 and November 5, 2019. Investors have until November 20, 2020...
Nov 18, 2020 03:12 pm ET
FLDM CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Lead Plaintiff Deadline in a Securities Fraud Class Action Against Fluidigm Corporation
Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the securities...
Nov 18, 2020 10:00 am ET
FLDM & WRTC Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Lead Deadlines
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Nov 18, 2020 10:00 am ET
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fluidigm Corporation (FLDM)
LOS ANGELES, Nov. 18, 2020 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming November 20, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Fluidigm Corporation ("Fluidigm" or "Company") (NASDAQ: FLDM) securities between February 7, 2019 and November 5, 2019, inclusive (the "Class Period").
Nov 17, 2020 09:00 pm ET
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Fluidigm Corporation and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors that...
Nov 17, 2020 11:45 am ET
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fluidigm Corporation (FLDM)
The Law Offices of Frank R. Cruz reminds investors of the upcoming November 20, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Fluidigm Corporation (“Fluidigm” or the “Company”) (NASDAQ:
Nov 17, 2020 08:30 am ET
Fluidigm COVID-19 Community Connect Program Builds a Network of Testing Partners to Increase Access of Saliva-Based SARS-CoV-2 Testing for Communities
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced COVID-19 Community Connect, a program to link federal, state and local governmental...
Nov 16, 2020 10:17 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fluidigm Corporation - FLDM
Pomerantz LLP is investigating claims on behalf of investors of Fluidigm Corporation (“Fluidigm” or the “Company”) (NASDAQ: FLDM). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Nov 16, 2020 11:15 am ET
DEADLINE ALERT for FLDM, GOCO, and NXTC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Nov 13, 2020 05:52 pm ET
FLDM FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Reminds Fluidigm Corporation Investors of Important November 20 Deadline in Securities Class Action - FLDM
NEW YORK, Nov. 13, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fluidigm Corporation (NASDAQ: FLDM) between February 7, 2019 and November 5, 2019, inclusive (the "Class Period") of the important November 20, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Fluidigm investors under the federal securities laws.
Nov 13, 2020 09:51 am ET
FLDM LOOMING DEADLINE: Zhang Investor Law Alerts Investors to Imminent Deadline in Securities Class Action Lawsuit Against  Fluidigm Corporation – FLDM
Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of  Fluidigm Corporation (NASDAQ: FLDM) between February 7, 2019 and November 5, 2019, inclusive. If you wish to serve as lead plaintiff, you must move...
Nov 13, 2020 08:00 am ET
Portnoy Law Firm: Fluidigm Corporation Investors: Last Days to Participate Actively in the Class Action Lawsuit
The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Fluidigm Corporation (NASDAQ: FLDM) investors that acquired shares between February 17, 2019 and November 5, 2019. Investors have until November 20, 2020...
Nov 12, 2020 03:52 pm ET
IMPORTANT NOV. 20 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Fluidigm Corporation – FLDM
Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Fluidigm Corporation (NASDAQ: FLDM) from February 7, 2019 through November 5, 2019, inclusive (the “Class Period”). The lawsuit...
Nov 12, 2020 11:30 am ET
DEADLINE ALERT for NKLA, NNOX, FLDM, FAF: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Nov 11, 2020 04:57 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fluidigm Corporation - FLDM
Pomerantz LLP is investigating claims on behalf of investors of Fluidigm Corporation (“Fluidigm” or the “Company”) (NASDAQ: FLDM).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Nov 11, 2020 03:52 pm ET
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Fluidigm Corporation Investors of Important November 20 Deadline in Securities Class Action – FLDM
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fluidigm Corporation (NASDAQ: FLDM) between February 7, 2019 and November 5, 2019, inclusive (the “Class Period”) of the important November 20, 2020 lead...
Nov 10, 2020 11:30 am ET
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fluidigm Corporation (FLDM)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming November 20, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Fluidigm Corporation (“Fluidigm”...
Nov 10, 2020 09:26 am ET
FLDM INVESTOR DEADLINE: Bernstein Liebhard Reminds Investors of the Lead Plaintiff Deadline in a Securities Fraud Class Action Against Fluidigm Corporation
NEW YORK, Nov. 10, 2020 /PRNewswire/ --Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the securities of Fluidigm Corporation ("Fluidigm" or the "Company") (NASDAQ: FLDM) between February 7, 2019, and November 5, 2019(the "Class Period"). The lawsuit filed in the United States District Court for the Northern District of California alleges violations of the Securities Exchange Act of 1934.
Nov 10, 2020 08:30 am ET
Fluidigm to Present at Upcoming Health Care Investor Conference
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that the company’s management will participate in investor meetings and present...
Nov 09, 2020 08:00 pm ET
FLUIDIGM ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Fluidigm Corporation and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors that purchased...
Nov 09, 2020 11:00 am ET
DEADLINE ALERT for FLDM, GOCO, and NXTC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Nov 08, 2020 02:15 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fluidigm Corporation - FLDM
Pomerantz LLP is investigating claims on behalf of investors of Fluidigm Corporation (“Fluidigm” or the “Company”) (NASDAQ: FLDM).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980....
Nov 06, 2020 05:06 pm ET
INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Fluidigm Corporation and Encourages Investors to Contact the Firm Before November 23, 2020
The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Fluidigm Corporation (“Fluidigm” or the “Company”)...
Nov 05, 2020 04:05 pm ET
Fluidigm Announces Third Quarter 2020 Financial Results
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced financial results for the third quarter ended September 30, 2020. Financial...
Nov 05, 2020 02:19 pm ET
FLDM CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Lead Plaintiff Deadline in a Securities Fraud Class Action Against Fluidigm Corporation
Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the securities...
Nov 05, 2020 02:02 pm ET
FLDM DEADLINE: Zhang Investor Law Alerts Investors to Looming Deadline in Securities Class Action Lawsuit Against Fluidigm Corporation – FLDM
Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of  Fluidigm Corporation (NASDAQ: FLDM) between February 7, 2019 and November 5, 2019, inclusive.   If you wish to serve as lead plaintiff, you must...
Nov 05, 2020 08:30 am ET
Fluidigm and Healthvana Partner to Offer COVID-19 Test Results Delivery through Innovative Digital Platform
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it has partnered with Healthvana Inc., the nation’s leading patient platform for...
Nov 04, 2020 03:08 pm ET
SHAREHOLDER DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Fluidigm Corporation– FLDM; IMPORTANT NOV. 20 DEADLINE– FLDM
Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Fluidigm Corporation (NASDAQ: FLDM) from February 7, 2019 through November 5, 2019, inclusive (the “Class Period”). The lawsuit...
Nov 03, 2020 11:30 am ET
DEADLINE ALERT for GOL, NKLA, NNOX, FLDM: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Nov 03, 2020 11:00 am ET
DEADLINE ALERT for FLDM, GOCO, and NXTC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Nov 03, 2020 08:30 am ET
Fluidigm Mass Cytometry Technologies, Including CyTOF, Imaging Mass Cytometry and Maxpar Direct, Utilized in More than 100 National Clinical Trials
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that its mass cytometry technologies, including CyTOF® , Imaging Mass Cytometry...
Nov 02, 2020 10:03 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Fluidigm Corporation – FLDM
Pomerantz LLP is investigating claims on behalf of investors of Fluidigm Corporation (“Fluidigm” or the “Company”) (NASDAQ: FLDM). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Nov 02, 2020 12:00 pm ET
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fluidigm Corporation (FLDM)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming November 20, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Fluidigm Corporation (“Fluidigm”...
Nov 02, 2020 08:30 am ET
Dante Labs Launching COVID-19 Testing in Europe Utilizing Fluidigm Pathogen Detection Kit on Biomark HD Platform
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that Dante Labs, a global pioneer in direct-to-consumer genomic testing, will be...
Oct 31, 2020 11:31 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fluidigm Corporation - FLDM
NEW YORK, Oct. 31, 2020 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Fluidigm Corporation ("Fluidigm" or the "Company") (NASDAQ: FLDM).  Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Oct 30, 2020 04:51 pm ET
ROSEN, A LEADING LAW FIRM, Reminds Fluidigm Corporation Investors of Important November 20 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – FL
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fluidigm Corporation (NASDAQ: FLDM) between February 7, 2019 and November 5, 2019, inclusive (the “Class Period”) of the important November 20, 2020 lead...
Oct 30, 2020 03:55 pm ET
INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Fluidigm Corporation and Encourages Investors to Contact the Firm Before November 23, 2020
The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Fluidigm Corporation (“Fluidigm” or the “Company”)...
Oct 29, 2020 02:32 pm ET
FLDM CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Lead Plaintiff Deadline in a Securities Fraud Class Action Against Fluidigm Corporation
Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the securities...
Oct 27, 2020 12:00 pm ET
DEADLINE ALERT for FLDM, GOCO, and NXTC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Oct 27, 2020 11:00 am ET
DEADLINE ALERT for GOL, NKLA, NNOX, FLDM: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Oct 27, 2020 09:47 am ET
FLDM INVESTOR DEADLINE: Bernstein Liebhard Reminds Investors of the Lead Plaintiff Deadline in a Securities Fraud Class Action Against Fluidigm Corporation
NEW YORK, Oct. 27, 2020 /PRNewswire/ --Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the securities of Fluidigm Corporation ("Fluidigm" or the "Company") (NASDAQ: FLDM) between February 7, 2019, and November 5, 2019(the "Class Period"). The lawsuit filed in the United States District Court for the Northern District of California alleges violations of the Securities Exchange Act of 1934.
Oct 26, 2020 08:39 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Fluidigm Corporation – FLDM
Pomerantz LLP is investigating claims on behalf of investors of Fluidigm Corporation (“Fluidigm” or the “Company”) (NASDAQ: FLDM). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Oct 26, 2020 05:27 pm ET
ROSEN, RECOGNIZED INVESTOR COUNSEL, Reminds Fluidigm Corporation Investors of Important November 20 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact
NEW YORK, Oct. 26, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fluidigm Corporation (NASDAQ: FLDM) between February 7, 2019 and November 5, 2019, inclusive (the "Class Period") of the important November 20, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Fluidigm investors under the federal securities laws.
Oct 24, 2020 05:45 pm ET
Rosen, A Leading and Longstanding Firm, Reminds Fluidigm Corporation Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – F
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fluidigm Corporation (NASDAQ: FLDM) between February 7, 2019 and November 5, 2019, inclusive (the “Class Period”) of the important November 20, 2020 lead...
Oct 22, 2020 01:19 pm ET
FLDM CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Lead Plaintiff Deadline in a Securities Fraud Class Action Against Fluidigm Corporation
Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the securities...
Oct 21, 2020 01:00 pm ET
NXTC, FLDM & WRTC Class Action Reminders: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Upcoming Lead Deadlines
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Oct 21, 2020 11:45 am ET
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Fluidigm Corporation (FLDM) Investors
LOS ANGELES, Oct. 21, 2020 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Fluidigm Corporation ("Fluidigm" or the "Company") (NASDAQ: FLDM) securities between February 7, 2019 and November 5, 2019, inclusive (the "Class Period").  Fluidigm investors have until November 20, 2020 to file a lead plaintiff motion.
Oct 19, 2020 01:00 pm ET
DEADLINE ALERT for GOL, NKLA, NNOX, FLDM: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Oct 19, 2020 09:31 am ET
Thinking about buying stock in Fluidigm Corp, Hertz, Duluth Holdings, Delta Air Lines, or Norwegian Cruise Line?
NEW YORK, Oct. 19, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for FLDM, HTZ, DLTH, DAL, and NCLH.
Oct 17, 2020 06:45 pm ET
ROSEN, A TOP RANKED LAW FIRM, Reminds Fluidigm Corporation Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – FLDM
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fluidigm Corporation (NASDAQ: FLDM) between February 7, 2019 and November 5, 2019, inclusive (the “Class Period”) of the important November 20, 2020 lead...
Oct 15, 2020 02:19 pm ET
DEADLINE ALERT for FLDM, GOCO, and NXTC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Oct 14, 2020 12:21 pm ET
FLDM CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Lead Plaintiff Deadline in a Securities Fraud Class Action Against Fluidigm Corporation
Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the securities...
Oct 14, 2020 11:30 am ET
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fluidigm Corporation (FLDM)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming November 20, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Fluidigm Corporation (“Fluidigm”...
Oct 13, 2020 09:14 am ET
FLDM INVESTOR DEADLINE: Bernstein Liebhard Reminds Investors of the Lead Plaintiff Deadline in a Securities Fraud Class Action Against Fluidigm Corporation
NEW YORK, Oct. 13, 2020 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the securities of Fluidigm Corporation ("Fluidigm" or the "Company") (NASDAQ: FLDM) between February 7, 2019, and November 5, 2019(the "Class Period"). The lawsuit filed in the United States District Court for the Northern District of California alleges violations of the Securities Exchange Act of 1934.
Oct 12, 2020 09:31 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fluidigm Corporation - FLDM
Pomerantz LLP is investigating claims on behalf of investors of Fluidigm Corporation (“Fluidigm” or the “Company”) (NASDAQ: FLDM). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Oct 12, 2020 11:45 am ET
ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Reminds Fluidigm Corporation Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fluidigm Corporation (NASDAQ: FLDM) between February 7, 2019 and November 5, 2019, inclusive (the “Class Period”) of the important November 20, 2020 lead...
Oct 09, 2020 01:00 pm ET
DEADLINE ALERT for GOL, NKLA, NNOX, FLDM: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Oct 08, 2020 11:30 am ET
DEADLINE ALERT for NNOX, FLDM, and NXTC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Oct 08, 2020 08:30 am ET
Fluidigm to Offer Millions of Advanta COVID-19 Tests at Low Cost to U.S. Colleges and Universities
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a program to expand availability of Fluidigm® COVID-19 tests for U.S. colleges and...
Oct 07, 2020 12:09 pm ET
FLDM CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Lead Plaintiff Deadline in a Securities Fraud Class Action Against Fluidigm Corporation
Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the securities...
Oct 06, 2020 04:02 pm ET
Fluidigm Announces Conference Call and Webcast of Third Quarter 2020 Financial Results
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will report third quarter 2020 financial results on Thursday, November 5,...
Oct 06, 2020 12:35 pm ET
FLDM STOCK ALERT: Zhang Investor Law Announces Securities Class Action Lawsuit Against Fluidigm Corporation – FLDM
Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Fluidigm Corporation (NASDAQ: FLDM) between February 7, 2019 and November 5, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover...
Oct 05, 2020 05:29 pm ET
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Fluidigm Corporation Investors of Important November 20 Deadline in Securities Class Action – FLDM
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fluidigm Corporation (NASDAQ: FLDM) between February 7, 2019 and November 5, 2019, inclusive (the “Class Period”) of the important November 20, 2020 lead plaintiff deadline. The lawsuit seeks to recover damages for Fluidigm investors under the federal securities laws.
Oct 02, 2020 11:45 am ET
DEADLINE ALERT for FLDM, GOCO, and NXTC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Oct 02, 2020 11:00 am ET
FLDM Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fluidigm Corporation Investors of Class Action and Encourages Shareholders to Contact the Firm
Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fluidigm Corporation ("Fluidigm” or "the Company") (NASDAQ: FLDM) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Fluidigm securities between February 7, 2019 and November 5, 2019, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm’s site:
Sep 30, 2020 10:07 am ET
FLDM CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Lead Plaintiff Deadline in a Securities Fraud Class Action Against Fluidigm Corporation
Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the securities...
Sep 29, 2020 12:00 pm ET
DEADLINE REMINDER: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fluidigm Corporation (FLDM)
Law Offices of Howard G. Smith reminds investors of the upcoming November 20, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Fluidigm Corporation (“Fluidigm” or the “Company”) (NASDAQ: FLDM) securities between February 7, 2019 and November 5, 2019, inclusive (the “Class Peri
Sep 28, 2020 07:30 pm ET
ROSEN, A TOP RANKED LAW IFRM, Announces Filing of Securities Class Action Lawsuit Against Fluidigm Corporation; Encourages Investors with Losses in Excess of $100K to Contact the Firm – FLDM
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Fluidigm Corporation (NASDAQ: FLDM) between February 7, 2019 and November 5, 2019, inclusive (the “Class...
Sep 28, 2020 10:22 am ET
FLDM INVESTOR DEADLINE: Bernstein Liebhard Reminds Investors of the Lead Plaintiff Deadline in a Securities Fraud Class Action Against Fluidigm Corporation
Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the securities of Fluidigm Corporation (“Fluidigm” or the “Company”) (NASDAQ: FLDM) between February 7, 2019, and November 5, 2019(the “Class Period”). The lawsuit filed in the United States District Court for the Northern District of California alleges violations of the Securities Exchange Act of 1934.
Sep 25, 2020 11:30 am ET
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fluidigm Corporation (FLDM)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming November 20, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Fluidigm Corporation (“Fluidigm” or “Company”) (NASDAQ:
Sep 25, 2020 11:09 am ET
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fluidigm Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the F
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Fluidigm Corporation (“Fluidigm” or “the Company”) (NASDAQ:
Sep 25, 2020 10:01 am ET
FLDM SHAREHOLDER ALERT: Bernstein Liebhard Announces that a Securities Fraud Class Action has Been Filed Against Fluidigm Corporation
Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action has been filed on behalf of investors that purchased or acquired the securities of Fluidigm Corporation (“Fluidigm” or the “Company”) (NASDAQ: FLDM) between February 7, 2019, and November 5, 2019(the “Class Period”). The lawsuit filed in the United States District Court for the Northern District of California alleges violations of the Securities Exchange Act of 1934.
Sep 25, 2020 10:00 am ET
FLDM Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fluidigm Corporation Investors of Class Action and Encourages Shareholders to Contact the Firm
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fluidigm Corporation ("Fluidigm” or "the Company") (NASDAQ: FLDM) and certain of its officers, on behalf of...
Sep 24, 2020 10:29 pm ET
Fluidigm Corporation Investors: Company Investigated by the Portnoy Law Firm
The Portnoy Law Firm advises Fluidigm Corporation ("Fluidigm" or the "Company") (NASDAQ: FLDM) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors. Investors are...
Sep 24, 2020 06:07 pm ET
INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Fluidigm Corporation 
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Fluidigm Corporation (“Fluidigm” or the “Company”) (NASDAQ:
Sep 24, 2020 02:27 pm ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fluidigm Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Fluidigm Corporation (“Fluidigm” or “the Company”) (NASDAQ:
Sep 24, 2020 12:40 pm ET
FLDM EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Fluidigm Corporation – FLDM
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Fluidigm Corporation (NASDAQ: FLDM) between February 7, 2019 and November 5, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Fluidigm investors under the federal securities laws.
Sep 24, 2020 09:47 am ET
FLDM INVESTOR ALERT: Bernstein Liebhard is Investigating Fluidigm Corporation For Violations of the Securities Laws
Bernstein Liebhard, a nationally acclaimed investor rights law firm, is investigating potential securities fraud claims on behalf of shareholders of Fluidigm Corporation ("Fluidigm" or the "Company") (NASDAQ: FLDM) resulting from allegations that Fluidigm might have issued misleading information to the investing public.
Sep 23, 2020 05:11 pm ET
Shareholder Alert: Robbins LLP Announces that Fluidigm Corporation (FLDM) is Being Sued for Misleading Shareholders
Shareholder rights law firm Robbins LLP announces that a shareholder of Fluidigm Corporation (NASDAQ: FLDM) has filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between February 7, 2019 and November 5, 2019. Fluidigm manufactures and markets products and services tha
Sep 23, 2020 11:33 am ET
FLUIDIGM CORPORATION CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Northern
Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors who purchased Fluidigm Corporation...
Sep 23, 2020 09:02 am ET
FLDM LOSSES ALERT: Bernstein Liebhard is Investigating Fluidigm Corporation For Violations of the Securities Laws
Bernstein Liebhard, a nationally acclaimed investor rights law firm, is investigating potential securities fraud claims on behalf of shareholders of Fluidigm Corporation ("Fluidigm" or the "Company") (NASDAQ: FLDM) resulting from allegations that Fluidigm might have issued misleading information to the investing public.
Sep 22, 2020 02:00 pm ET
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Fluidigm Corporation (FLDM) Investors
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Fluidigm Corporation (“Fluidigm” or the “Company”) (NASDAQ:
Sep 22, 2020 12:00 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Fluidigm Corporation (FLDM) Investors
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Fluidigm Corporation (“Fluidigm” or the “Company”) (NASDAQ: FLDM) securities between February 7, 2019 and November 5, 2019, inclusive (the “Class Period”). Fluidigm investors have until November 20, 2020
Sep 21, 2020 08:56 pm ET
FLDM CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Fluidigm Corporation
Glancy Prongay & Murray LLP (“GPM”) announces that it has filed a class action lawsuit in the United States District Court for the Northern District of California captioned Saintjermain v. Fluidigm Corporation, et al., (Case No. 20-cv-06617) on behalf of persons and entities that purchased or otherwise acquired Fluidigm Corpo
Sep 21, 2020 12:12 pm ET
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Fluidigm Corporation (FLDM) on Behalf of Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Fluidigm Corporation (“Fluidigm” or the “Company”) (NASDAQ:
Sep 16, 2020 08:45 am ET
Fluidigm Joins Global Consortium of Cancer Prevention Experts
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced its participation in CANCERPREV, a research and training program composed of top-tier...
Sep 16, 2020 08:30 am ET
ImmunoGenomics and Vero Diagnostics Providing COVID-19 Testing with Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay on Biomark HD Platform
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that ImmunoGenomics, based in metropolitan Houston, and Vero Diagnostics of Research...
Sep 15, 2020 02:15 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Fluidigm Corporation (FLDM) on Behalf of Investors
Law Offices of Howard G. Smith continues its investigation on behalf of Fluidigm Corporation ("Fluidigm" or the "Company") (NASDAQ: FLDM) investors concerning the Company’s possible violations of federal securities laws.
Sep 15, 2020 08:30 am ET
Fluidigm Announces Agenda for 9th Annual Mass Cytometry Summit
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the agenda for the 9th Annual Fluidigm Mass Cytometry Summit on September 23. The...
Sep 10, 2020 12:56 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Fluidigm Corporation (FLDM) on Behalf of Investors
Law Offices of Howard G. Smith announces an investigation on behalf of Fluidigm Corporation ("Fluidigm" or the "Company") (NASDAQ: FLDM) investors concerning the Company’s possible violations of federal securities laws.
Sep 08, 2020 08:30 am ET
Fluidigm Achieves Initial Milestone under NIH Rapid Acceleration of Diagnostics Agreement
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced progress on the Company’s Rapid Acceleration of Diagnostics (RADx) project.Fluidigm...
Sep 04, 2020 08:10 pm ET
The Law Offices of Frank R. Cruz Announces Investigation of Fluidigm Corporation (FLDM) on Behalf of Investors
The Law Offices of Frank R. Cruz announces an investigation on behalf of Fluidigm Corporation ("Fluidigm" or the "Company") (NASDAQ:
Sep 02, 2020 04:02 pm ET
Fluidigm to Participate at the 2020 Cantor Virtual Global Healthcare Conference
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that the company’s management will participate in investor meetings and present...
Aug 25, 2020 11:00 pm ET
Fluidigm Granted FDA Emergency Use Authorization for Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR  Assay for COVID-19
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug...
Aug 06, 2020 04:05 pm ET
Fluidigm Announces Second Quarter 2020 Financial Results
Fluidigm Corporation (Nasdaq:FLDM) today announced financial results for the second quarter ended June 30, 2020. Financial Highlights Second Quarter 2020 Second quarter revenue decreased 8 percent to $26.1 million from $28.2 million in the...
Aug 04, 2020 08:30 am ET
Fluidigm and De Novo Software to Offer Mass Cytometry Customers a Streamlined Solution for Data Analysis
Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a distribution agreement with De Novo Software™ to provide customers with access to...
Jul 31, 2020 11:10 am ET
Fluidigm Selected for $37 Million Project under National Institutes of Health RADx Initiative
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced execution of a letter contract with the National Institutes of Health, National...
Jul 20, 2020 08:30 am ET
GnomeDX Files for FDA Emergency Use Authorization for Rapid Turnaround Real-Time RT-PCR COVID-19 Test Utilizing the Fluidigm Biomark HD Platform
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that Gnome Diagnostics, LLC (GnomeDX), a leading pharmacogenomics testing company, is...
Jul 06, 2020 04:02 pm ET
Fluidigm Announces Conference Call and Webcast of Second Quarter 2020 Financial Results
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will report second quarter 2020 financial results on Thursday, August 6,...
Jun 29, 2020 08:30 am ET
Multi-Site Study of COVID-19 Patients Utilizing Fluidigm Mass Cytometry Technology and Maxpar Direct Immune Profiling Assay
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that Fluidigm® mass cytometry technology and the Maxpar® Direct™ Immune Profiling...
Jun 24, 2020 08:30 am ET
Integrated Genetics Lab Services Conducting COVID-19 Testing in Spain Utilizing Fluidigm Biomark HD Platform
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that Integrated Genetics Lab Services (iGLS), a leading provider of advanced and...
Jun 17, 2020 08:30 am ET
New Collaboration with Bethyl Laboratories Expands Antibody Offerings for Hyperion Imaging System
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a collaboration with Bethyl Laboratories to provide broader verified antibody access...
Jun 15, 2020 09:31 am ET
Thinking about buying stock in Fluidigm Corp, Xenetic Biosciences, Delta Air Lines, Occidental Petroleum Corp, or FuelCell Energy?
NEW YORK, June 15, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for FLDM, XBIO, DAL, OXY, and FCEL.
Jun 12, 2020 08:00 pm ET
Fluidigm Files for FDA Emergency Use Authorization for Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Test for COVID-19
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced it has filed for Emergency Use Authorization (EUA) from the U.S. Food and Drug...
May 19, 2020 08:30 am ET
University of Paris Researchers Utilize Fluidigm Mass Cytometry and Maxpar Direct Immune Profiling Assay to Identify Distinct Phenotype among Patients with Severe COVID-19
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that researchers at the University of Paris have utilized mass cytometry to identify...
May 13, 2020 04:02 pm ET
Fluidigm to Present at Upcoming Health Care Investor Conferences
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that Chris Linthwaite, President and Chief Executive Officer, and Vikram Jog, Chief...
May 07, 2020 04:05 pm ET
Fluidigm Announces First Quarter 2020 Financial Results
Fluidigm Corporation (Nasdaq:FLDM) today announced financial results for the first quarter ended March 31, 2020. Financial Highlights First Quarter 2020 First quarter revenue decreased 8 percent to $27.6 million from $30.1 million. Total...
May 07, 2020 04:03 pm ET
Fluidigm Expands Accessibility of Mass Cytometry and Imaging Mass Cytometry Technology with New Therapeutic Insights Services
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced its new Therapeutic Insights Services business, designed to provide researchers with...
May 04, 2020 09:31 am ET
Thinking about buying stock in Applied DNA Sciences, Agile Therapeutics, Canopy Growth Corp, Fluidigm Corp, or Capricor Therapeutics?
NEW YORK, May 4, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APDN, AGRX, CGC, FLDM, and CAPR.
Apr 23, 2020 08:30 am ET
OU Medicine, University of Oklahoma Health Sciences Center and Oklahoma Medical Research Foundation File for FDA Emergency Use Authorization for COVID-19 Detection Test Utilizing Fluidigm Technology
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that OU Medicine, the University of Oklahoma and the Oklahoma Medical Research...
Apr 20, 2020 04:06 pm ET
Fluidigm Announces Conference Call and Webcast of First Quarter 2020 Financial Results
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that it will report first quarter 2020 financial results on Thursday, May 7, 2020,...
Apr 14, 2020 04:05 pm ET
Fluidigm Provides Update on COVID-19 Impact and Preliminary Revenue Estimate for First Quarter 2020
Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today provided an update on the impact of the COVID-19 pandemic on its business and announced...
Apr 02, 2020 08:30 am ET
Fluidigm CyTOF Technology Used to Evaluate Stem Cell Therapy as a Potential Treatment for COVID-19 Pneumonia
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that Fluidigm® CyTOF® technology was used in a clinical study producing preliminary...
Mar 16, 2020 08:30 am ET
Consortium of Medical Schools Led by Mount Sinai Fast-Tracking COVID-19 Detection Test Utilizing Fluidigm Microfluidics Technology
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that a consortium of medical schools led by the Icahn School of Medicine at Mount...
Mar 11, 2020 08:30 am ET
Fluidigm and SIgN Establish the First Center of Excellence in Singapore to Advance Imaging Mass Cytometry
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the establishment of a new Center of Excellence (CoE) for Imaging Mass Cytometry™...
Mar 10, 2020 08:30 am ET
Fluidigm Introduces AccuLift Laser Capture Microdissection System to Advance Translational and Clinical Pathology Research
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the introduction of the AccuLift™ Laser Capture Microdissection System. Ideal for...
Mar 03, 2020 08:00 am ET
Fluidigm and Next Gen Diagnostics Enter into Agreement to Improve the Efficiency of Pathogen Sample Preparation for Microbial Whole Genome Sequencing
Fluidigm Corporation (Nasdaq:FLDM), an industry leader in microfluidics technology, and Next Gen Diagnostics (NGD), a Wellcome Sanger Institute-based leader in the automation of pathogen bioinformatics, today announce an exclusive agreement that...
Feb 26, 2020 08:30 am ET
Fluidigm Completes Acquisition of InstruNor AS
Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that it has completed the acquisition of InstruNor AS, the privately held provider...
Feb 12, 2020 04:05 pm ET
Fluidigm to Participate in Upcoming Investor Conferences
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that Chris Linthwaite, President and Chief Executive Officer, will present updates on...
Feb 10, 2020 04:05 pm ET
Fluidigm Announces Fourth Quarter and Full Year 2019 Financial Results
Fluidigm Corporation (NASDAQ:FLDM) today announced financial results for the fourth quarter and full year ended December 31, 2019. Financial Highlights Fourth Quarter 2019 Revenue of $32.4 million was flat, with instrument revenue growth of 16...
Feb 10, 2020 04:02 pm ET
Fluidigm Establishes Center of Excellence at NCI-Designated Comprehensive Cancer Center to Advance Imaging Mass Cytometry
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will establish a new Center of Excellence (CoE) for Imaging Mass Cytometry™...
Feb 10, 2020 08:00 am ET
Fluidigm CyTOF Technology Selected by Covance to Develop Highly Multiplexed Human Immune Profiling Services
Fluidigm (Nasdaq:FLDM) today announced that Covance, the drug development business of LabCorp® (NYSE: LH), a leading global life sciences company, has selected Fluidigm’s CyTOF® technology and the industry-leading Maxpar® Direct™ Immune Profiling...
Jan 20, 2020 11:32 am ET
Landmark Nature Publication Demonstrates the Power of the Fluidigm Hyperion Imaging System to Identify Novel Cellular Signatures That Correlate with Distinct Clinical Outcomes
Fluidigm Corporation (NASDAQ:FLDM), the global leader in high-multiplex single-scan tissue imaging, today announced that a new landmark study demonstrates the potential for Imaging Mass Cytometry™ (IMC™) on the Hyperion™ Imaging System to transform...
Jan 14, 2020 08:30 am ET
Fluidigm Provides Preliminary Financial Results for Fourth Quarter and Fiscal Year 2019
Fluidigm Corporation (NASDAQ: FLDM) today provided preliminary financial highlights for the fourth quarter ended December 31, 2019. Fourth Quarter Preliminary Financial Highlights Fourth quarter revenue of  $32.0-$32.4 million, at the upper end...
Jan 13, 2020 08:30 am ET
MOgene Selects Fluidigm Advanta Assays and Juno System to Expand Its NGS Services Portfolio
MOgene, a leading provider of genomic and bioinformatic services in St. Louis, today announced it has selected Fluidigm’s (NASDAQ:FLDM) Advanta™ assays and microfluidics-based Juno™ system to expand its next-generation sequencing (NGS) services...
Dec 18, 2019 08:30 am ET
The University of Michigan Protein Assembly Lab Selects Hyperion Imaging System for Research In Cancer Immunotherapy and Immune Phenotyping
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that The University of Michigan Protein Assembly Lab, a hub for collaborative and...
Dec 12, 2019 08:30 am ET
Fluidigm Named to Greater Toronto's Top Employers for 2020
Fluidigm Canada, a subsidiary of Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, has been named one of Greater Toronto's Top Employers for 2020, an...
Dec 10, 2019 08:30 am ET
Fluidigm Expands Maxpar Antibody Portfolio for High-Multiplex Tissue Imaging
Fluidigm Corporation (NASDAQ:FLDM), the global leader in high-multiplex single-scan tissue imaging, today announced the availability of more than 100 pathologist-verified Maxpar® antibodies for use with Imaging Mass Cytometry™ (IMC™) on the...
Dec 09, 2019 08:30 am ET
Fluidigm Receives Life Science Industry Award for the Maxpar Direct Immune Profiling System
BioInformatics Inc., the leading research and advisory firm serving the life science tools market, recognized Fluidigm (NASDAQ:FLDM) with the Gold Award for the Best New Product in Cell Biology for the Maxpar® Direct™ Immune Profiling System. The...
Nov 20, 2019 11:21 am ET
Fluidigm Corporation Announces Pricing of Private Offering of $50 Million of 5.25% Convertible Senior Notes
Fluidigm Corporation (NASDAQ: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the pricing of $50 million aggregate principal amount of 5.25% convertible senior...
Nov 20, 2019 06:36 am ET
Fluidigm Corporation Announces Proposed Private Offering of $45 Million of Convertible Senior Notes
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it intends to offer, subject to market conditions and other factors, $45...
Nov 13, 2019 04:05 pm ET
Fluidigm to Participate in the 31st Annual Piper Jaffray Healthcare Conference
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that the company’s management will participate in the 31st Annual Piper Jaffray...
Nov 05, 2019 04:05 pm ET
Fluidigm Announces Third Quarter 2019 Financial Results
Fluidigm Corporation (NASDAQ:FLDM) today announced financial results for the third quarter ended September 30, 2019. Financial Highlights Third quarter revenue decreased 8.5 percent to $26.5 million from $29.0 million, with consumables revenue...
Nov 05, 2019 04:02 pm ET
Fluidigm Drives a New Standard in Human Immune Profiling
Fluidigm Corporation (NASDAQ:FLDM) today announced it has exceeded $1 million in revenue from its industry-leading Maxpar® Direct™ Immune Profiling Assay™ and Maxpar Human Immune Monitoring Panel Kit. Used by more than 100 academic, pharmaceutical...
Oct 15, 2019 04:15 pm ET
Fluidigm Showcases RNA Sequencing Innovations Using Microfluidics Technology at the 2019 American Society of Human Genetics (ASHG) Meeting
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, will showcase innovative RNA sequencing applications using microfluidics technology at the American...
Oct 10, 2019 04:10 pm ET
Fluidigm Announces Conference Call and Webcast of Third Quarter 2019 Financial Results
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that it will report third quarter 2019 financial results on Tuesday, November 5,...
Sep 24, 2019 08:30 am ET
Fluidigm Becomes the First Company to Enable 50-Plex Cytometry Panels with the Release of Seven New Metal Antibody Labels
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it has launched seven new cadmium metal labeling kits for use with mass...
Sep 18, 2019 08:30 am ET
CyTOF Inventors Receive Prestigious Science and Technology Award from the Human Proteome Organization (HUPO)
The Human Proteome Organization (HUPO), an international scientific organization that promotes proteomics through international cooperation and collaborations, today recognized CyTOF® inventors Dr. Scott Tanner, Dr. Vladimir Baranov, Dr. Olga...
Sep 10, 2019 07:30 am ET
Fluidigm Files Patent Infringement Suit Against IONpath
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it has filed new legal action in the United States District Court for the...
Sep 09, 2019 08:30 am ET
Fluidigm Revolutionizes Next-Generation Sequencing RNA Library Preparation with Microfluidic Automation
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the launch of a breakthrough RNA sequencing library preparation workflow that...
Sep 04, 2019 08:30 am ET
Fluidigm Launches Imaging Mass Cytometry Immuno-Oncology Panel Kits and Advanced CyTOF Software at the 2019 World Molecular Imaging Congress (WMIC)
Fluidigm Corporation (NASDAQ:FLDM), the global leader in highly multiplexed single-scan tissue imaging, today announced the launch of three new Imaging Mass Cytometry™ Maxpar® Human Immuno-Oncology Panel Kits and an advanced CyTOF® Software...
Aug 27, 2019 08:30 am ET
Fluidigm and the Icahn School of Medicine at Mount Sinai Collaborate on Landmark Single-Cell Study of the Human Epigenome
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it has entered into a collaboration with the Icahn School of Medicine at Mount...
Aug 20, 2019 04:05 pm ET
Fluidigm to Participate in Upcoming Health Care Investor Conferences
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that the company’s management will participate in two upcoming investor conferences....

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.